Health Tidings Mergers & AcquisitionsSino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Sino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Read Post »
Health Tidings Mergers & AcquisitionsSerum Institute, DNDi Advance VIS513 Into Global Phase III Dengue Trial Serum Institute, DNDi Advance VIS513 Into Global Phase III Dengue Trial Read Post »
Health Tidings Mergers & AcquisitionsTeva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Teva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Read Post »
Health Tidings Mergers & AcquisitionsBayer Launches Clinical Trials Alliance With CU Anschutz Bayer Launches Clinical Trials Alliance With CU Anschutz Read Post »
Health Tidings Mergers & AcquisitionsSino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Sino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Read Post »
Health Tidings Mergers & AcquisitionsChemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Chemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Read Post »
Health Tidings Mergers & AcquisitionsPraxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Praxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Read Post »
Health Tidings Mergers & AcquisitionsVertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Vertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Read Post »
Health Tidings Mergers & AcquisitionsAstex Signs Breast Cancer Drug Discovery Deal with Genentech Astex Signs Breast Cancer Drug Discovery Deal with Genentech Read Post »
Health Tidings Mergers & AcquisitionsNovartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Novartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Read Post »
Health Tidings Mergers & AcquisitionsArcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Read Post »
Health Tidings Mergers & AcquisitionsTakeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Takeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Read Post »
Health Tidings Regulatory & Health Policy Women & Child HealthEMA Moves to Embed Women’s Health Across Europe’s Medicines Reg... EMA Moves to Embed Women’s Health Across Europe’s Medicines Reg... Read Post »
Health Tidings Mergers & AcquisitionsUnited Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... United Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... Read Post »
Health Tidings Mergers & AcquisitionsIpsen Acquires Memo Therapeutics, Adds Potravitug to Rare Disease Pipeline Ipsen Acquires Memo Therapeutics, Adds Potravitug to Rare Disease Pipeline Read Post »
Health Tidings Mergers & AcquisitionsInnovent Secures Exclusive China Rights to Lilly’s Verzenios Innovent Secures Exclusive China Rights to Lilly’s Verzenios Read Post »
Health Tidings Mergers & AcquisitionsIpsen to Acquire Kartos Therapeutics in Up to $1.75B Deal, Adds Myelofibros... Ipsen to Acquire Kartos Therapeutics in Up to $1.75B Deal, Adds Myelofibros... Read Post »
Health Tidings Mergers & AcquisitionsElixirgen and Nippon Shinyaku Partner to Advance Full-Length Dystrophin mRN... Elixirgen and Nippon Shinyaku Partner to Advance Full-Length Dystrophin mRN... Read Post »
Health Tidings Mergers & AcquisitionsMerck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Novartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Read Post »
Health Tidings Mergers & AcquisitionsIonis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Ionis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Eli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Read Post »
Health Tidings Mergers & AcquisitionsNuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Nuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Read Post »
Health Tidings Mergers & AcquisitionsInsilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Insilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Read Post »
Health Tidings Mergers & AcquisitionsAbbVie to Acquire Apogee Therapeutics for $10.9B, Expanding Immunology and ... AbbVie to Acquire Apogee Therapeutics for $10.9B, Expanding Immunology and ... Read Post »
Generics Mergers & AcquisitionsSamsung Bioepis and Organon Expand Canadian Biosimilar Portfolio with PYZCH... Samsung Bioepis and Organon Expand Canadian Biosimilar Portfolio with PYZCH... Read Post »
Health Tidings Mergers & AcquisitionsVoro and Alloy Partner to Develop Safer T-Cell Engager Therapies Voro and Alloy Partner to Develop Safer T-Cell Engager Therapies Read Post »
Health Tidings Mergers & AcquisitionsBiogen to Acquire RayThera in Up to $1 Billion Deal, Expanding Immunology P... Biogen to Acquire RayThera in Up to $1 Billion Deal, Expanding Immunology P... Read Post »
Mergers & AcquisitionsJazz and AbCellera Partner to Develop T-Cell Engagers for GI and Solid Tumo... Jazz and AbCellera Partner to Develop T-Cell Engagers for GI and Solid Tumo... Read Post »
Mergers & AcquisitionsRichter and Hetero Team Up on Generic Semaglutide for Global Markets Richter and Hetero Team Up on Generic Semaglutide for Global Markets Read Post »
Health Tidings Mergers & AcquisitionsServier, n-Lorem Launch ASO Research Partnership in Rare Neurology Servier, n-Lorem Launch ASO Research Partnership in Rare Neurology Read Post »
Health Tidings Mergers & AcquisitionsNovartis Expands Orionis Partnership in $1.4 Billion Molecular Glue Drug Di... Novartis Expands Orionis Partnership in $1.4 Billion Molecular Glue Drug Di... Read Post »
Health Tidings Mergers & AcquisitionsLilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Lilly Signs Potential $1 Billion Alzheimer’s Deal With AlzeCure Read Post »
Health Tidings Mergers & AcquisitionsGSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors GSK Acquires Nuvalent, Adding FDA-Reviewed ROS1 and ALK Inhibitors Read Post »
Mergers & AcquisitionsJohnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Johnson & Johnson Acquires Firefly Bio in $1 Billion Oncology Deal Read Post »
Health Tidings Mergers & AcquisitionsRoche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Roche Licenses Nurix’s BTK Degrader Bexobrutideg in Up to $2.3 Billion De... Read Post »
Health Tidings Mergers & AcquisitionsIncyte Bolsters Hematology Growth With $2 Billion Vega Buyout Incyte Bolsters Hematology Growth With $2 Billion Vega Buyout Read Post »
Mergers & AcquisitionsAlnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Alnylam Partners With Inceptive in Up to $2 Billion AI Drug Discovery Deal Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer IDEAYA and Roche Advance PRMT5 and Pan-RAS Inhibitors in Pancreatic Cancer Read Post »
Health Tidings Mergers & AcquisitionsAscidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Ascidian Secures Up to $1.9 Billion in Lilly Kidney Disease Partnership Read Post »
Health Tidings Mergers & AcquisitionsCytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion CytomX Secures Expanded Regeneron Partnership Worth Up to $4 Billion Read Post »
Health Tidings Mergers & AcquisitionsCEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million CEPI Backs Moderna’s Bundibugyo Ebola Vaccine with $50 Million Read Post »
Health Tidings Mergers & AcquisitionsServier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Servier Acquires Edgewise Muscular Dystrophy Business for Up to $2.65 Billi... Read Post »
Mergers & AcquisitionsAgios Lands Global Cevidoplenib Rights in Rare Hematology Push Agios Lands Global Cevidoplenib Rights in Rare Hematology Push Read Post »
Health Tidings Mergers & AcquisitionsPfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Pfizer and Innovent Strike Oncology Deal Worth Up to $10.5 Billion Read Post »
Health Tidings Mergers & AcquisitionsApogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Apogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Lilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Read Post »
Regulatory & Health PolicyChugai Wins Japan’s Top Invention Honor for Antibody Recycling Technology Chugai Wins Japan’s Top Invention Honor for Antibody Recycling Technology Read Post »
Regulatory & Health PolicyMHRA Proposes Accelerated Pathway for Rare Disease Therapies MHRA Proposes Accelerated Pathway for Rare Disease Therapies Read Post »
Mergers & AcquisitionsGilead Renews WHO Partnership to Fight Visceral Leishmaniasis Gilead Renews WHO Partnership to Fight Visceral Leishmaniasis Read Post »
